In recent years, there have been many studies in the literature showing that inflammatory markers are predictors of mortality in cardiovascular diseases.6-11 For example, there is good evidence that hematological and biochemical systemic inflammatory markers such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), inflammatory prognostic index (IPI), systemic immune-inflammatory index (SII), and multi-inflammatory index (MII) are both sensitive and reliable predictors of mortality in patients with unruptured AAA.8-11. Here, CRP is linked to triple-A syndrome.